HWAM
Hennion & Walsh Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.84M | Buy |
12,675
+1,666
| +15% | +$504K | 0.15% | 162 |
|
|
2025
Q1 | $3.65M | Buy |
11,009
+1,105
| +11% | +$366K | 0.16% | 162 |
|
|
2024
Q4 | $3.06M | Sell |
9,904
-9,013
| -48% | -$2.78M | 0.14% | 186 |
|
|
2024
Q3 | $4.01M | Sell |
18,917
-1,420
| -7% | -$301K | 0.19% | 132 |
|
|
2024
Q2 | $5.7M | Sell |
20,337
-11,981
| -37% | -$3.36M | 0.29% | 67 |
|
|
2024
Q1 | $8.63M | Buy |
32,318
+5,392
| +20% | +$1.44M | 0.46% | 31 |
|
|
2023
Q4 | $6.23M | Sell |
26,926
-9,046
| -25% | -$2.09M | 0.36% | 52 |
|
|
2023
Q3 | $5.25M | Sell |
35,972
-1,622
| -4% | -$237K | 0.34% | 59 |
|
|
2023
Q2 | $8.68M | Sell |
37,594
-9,085
| -19% | -$2.1M | 0.52% | 30 |
|
|
2023
Q1 | $11.3M | Buy |
46,679
+736
| +2% | +$178K | 0.69% | 18 |
|
|
2022
Q4 | $13.3M | Sell |
45,943
-5,064
| -10% | -$1.47M | 0.82% | 11 |
|
|
2022
Q3 | $3.32M | Sell |
51,007
-8,336
| -14% | -$542K | 0.22% | 122 |
|
|
2022
Q2 | $4.25M | Sell |
59,343
-14,391
| -20% | -$1.03M | 0.26% | 95 |
|
|
2022
Q1 | $7.24M | Buy |
73,734
+4,473
| +6% | +$439K | 0.38% | 62 |
|
|
2021
Q4 | $5.87M | Sell |
69,261
-4,675
| -6% | -$396K | 0.29% | 96 |
|
|
2021
Q3 | $5.9M | Buy |
73,936
+372
| +0.5% | +$29.7K | 0.31% | 78 |
|
|
2021
Q2 | $7.17M | Buy |
73,564
+1,222
| +2% | +$119K | 0.38% | 60 |
|
|
2021
Q1 | $8.46M | Buy |
+72,342
| New | +$8.46M | 0.51% | 33 |
|